| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 810 | 810 | 959 | 932 | 941 | 979 | 1,004 | 1,132 | 1,202 | 1,267 | 1,294 | 1,419 | 1,451 | 1,501 | 1,498 | 1,588 | 1,574 | 1,525 | 1,558 | 1,697 | 1,824 | 1,885 | 1,899 |
| Expenses | 743 | 745 | 859 | 863 | 872 | 914 | 941 | 1,061 | 1,119 | 1,171 | 1,213 | 1,324 | 1,350 | 1,385 | 1,395 | 1,452 | 1,429 | 1,373 | 1,412 | 1,531 | 1,648 | 1,695 | 1,746 |
| EBITDA | 67 | 65 | 101 | 69 | 69 | 65 | 63 | 71 | 83 | 95 | 81 | 96 | 102 | 116 | 103 | 136 | 145 | 152 | 146 | 166 | 177 | 190 | 153 |
| Operating Profit % | 7 % | 7 % | 10 % | 7 % | 7 % | 5 % | 5 % | 5 % | 6 % | 7 % | 6 % | 6 % | 6 % | 7 % | 6 % | 8 % | 8 % | 9 % | 8 % | 9 % | 9 % | 9 % | 7 % |
| Depreciation | 22 | 24 | 27 | 28 | 31 | 34 | 38 | 42 | 46 | 56 | 52 | 56 | 57 | 59 | 60 | 63 | 63 | 64 | 66 | 69 | 73 | 76 | 78 |
| Interest | 13 | 15 | 15 | 16 | 17 | 19 | 20 | 20 | 21 | 22 | 23 | 24 | 25 | 25 | 25 | 25 | 26 | 27 | 27 | 29 | 31 | 34 | 33 |
| Profit Before Tax | 32 | 26 | 58 | 25 | 22 | 13 | 5 | 9 | 16 | 17 | 5 | 16 | 20 | 32 | 18 | 48 | 57 | 61 | 53 | 69 | 73 | 80 | 42 |
| Tax | 9 | 8 | 12 | 5 | 5 | 1 | 1 | 2 | 3 | -9 | 1 | 2 | 6 | -2 | 4 | 9 | 11 | 10 | 10 | 13 | 16 | 16 | 9 |
| Net Profit | 23 | 18 | 46 | 20 | 17 | 11 | 4 | 7 | 13 | 27 | 4 | 15 | 14 | 34 | 14 | 39 | 46 | 51 | 42 | 56 | 58 | 64 | 33 |
| EPS in ₹ | 2.21 | 1.76 | 4.34 | 1.85 | 1.53 | 0.99 | 0.27 | 0.55 | 1.12 | 2.24 | 0.32 | 1.22 | 1.15 | 2.81 | 1.20 | 3.24 | 3.84 | 4.32 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 |
Medplus Health Services
Medplus Health Services
654.90
+0.65
(0.10%)
Market Cap
7,867.78 Cr
PE Ratio
37.29
Volume
1,22,436.00
Day High - Low
661.10 - 652.00
52W High-Low
1,022.20 - 645.00
Key Fundamentals
Market Cap
7,867.78 Cr
EPS
18.33
PE Ratio
37.29
PB Ratio
3.97
Book Value
164.43
EBITDA
678.70
Dividend Yield
0.00 %
Industry
Retail Sector
Pharmacy Retail Return on Equity
11.12
Debt to Equity
0.68
Analyst Rating and Forecast
- By Refinitiv from7 analysts
Actual
Company News
View All News
Medplus board comments on SEBI LODR fine
Sep 10, 2026
Sep 10, 2026Medplus Health Services board addressed exchange fine for non-compliance regarding independent director appointment. Cited interpretational difference, not willful default.
MedPlus board approves buying remaining 0.01% stake in OptivalSep 10, 2026
MedPlus Health Services board has approved the acquisition of the remaining 0.01% stake in Optival Health Solutions, moving toward full ownership of the subsidiary.
Medplus: Agilemed pledges 5.2% stakeAug 21, 2026
Aug 21, 2026Agilemed Investments has pledged 62,51,066 shares of Medplus Health Services, representing 5.20% of the total share capital. The encumbrance was created in favor of Catalyst Trusteeship Limited as Debenture Trustee.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,821.80 | #1 7,928.14 | 48.13 | 6,610.40 | #1 28.72 | 146 | #1 72.19 | 61.28 | |
654.90 | #2 7,867.78 | #2 37.29 | #1 6,963.80 | #2 12.60 | #1 220 | #2 -21.51 | 41.43 | |
72.90 | 207.50 | - | 9.20 | -4.17 | -2 | -166.67 | 42.56 | |
72.85 | 142.27 | #1 27.79 | 104.40 | 1.98 | 5 | - | 62.48 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
12.60 %
Net Income Growth
46.21 %
Cash Flow Change
-8.30 %
ROE
28.85 %
ROCE
18.79 %
EBITDA Margin (Avg.)
12.59 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 438 | 509 | 538 | 644 | 673 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 |
| Fixed Assets | 67 | 77 | 81 | 84 | 90 | 420 | 517 | 799 | 1,138 | 1,242 | 1,296 | 1,595 |
| Current Assets | 317 | 376 | 397 | 458 | 475 | 816 | 923 | 1,632 | 1,481 | 1,568 | 1,844 | 2,069 |
| Capital Work in Progress | 3 | 4 | 0 | 1 | 1 | 5 | 6 | 20 | 26 | 11 | 16 | 32 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 368 | 429 | 457 | 560 | 582 | 924 | 1,043 | 1,775 | 1,633 | 1,752 | 2,047 | 2,306 |
| Total Equity & Liabilities | 438 | 509 | 538 | 644 | 673 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 |
| Current Liabilities | 210 | 269 | 278 | 326 | 337 | 481 | 415 | 559 | 477 | 526 | 577 | 689 |
| Non Current Liabilities | 74 | 91 | 111 | 15 | 11 | 339 | 420 | 618 | 830 | 902 | 1,044 | 1,269 |
| Total Equity | 154 | 150 | 149 | 304 | 325 | 529 | 731 | 1,417 | 1,491 | 1,577 | 1,740 | 1,975 |
| Reserve & Surplus | 141 | 137 | 149 | 303 | 325 | 528 | 359 | 1,394 | 1,467 | 1,554 | 1,717 | 1,951 |
| Share Capital | 12 | 12 | 0 | 0 | 0 | 0 | 0 | 24 | 24 | 24 | 24 | 24 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 32 | -15 | -10 | 14 | 45 | 56 | -37 | -93 | 350 | -137 | -5 | 112 |
| Investing Activities | -16 | -32 | -15 | -18 | -19 | -28 | -35 | -703 | 429 | -83 | -318 | -128 |
| Operating Activities | -19 | -17 | 34 | 32 | 147 | -7 | 3 | 170 | 90 | 144 | 540 | 496 |
| Financing Activities | 67 | 35 | -29 | -1 | -83 | 90 | -6 | 440 | -170 | -198 | -228 | -256 |
Share Holding
| % Holding | Aug 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 96.68 % | 40.43 % | 40.43 % | 40.43 % | 40.43 % | 40.43 % | 40.43 % | 40.43 % | 40.41 % | 40.45 % | 40.39 % | 40.39 % | 40.39 % | 40.39 % | 40.34 % | 40.32 % | 40.29 % | 40.29 % | 40.22 % | 40.19 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 12.36 % | 0.00 % | 14.94 % | 14.85 % | 14.72 % | 15.23 % | 15.61 % | 16.42 % | 16.54 % | 16.83 % | 15.53 % | 14.38 % |
| DIIs | 0.00 % | 11.61 % | 11.99 % | 14.96 % | 14.31 % | 28.77 % | 28.16 % | 13.62 % | 25.49 % | 16.28 % | 22.47 % | 22.17 % | 27.97 % | 25.65 % | 26.19 % | 26.04 % | 26.52 % | 26.57 % | 27.82 % | 29.95 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 6.38 % | 5.83 % | 5.88 % | 6.22 % | 6.21 % | 6.13 % | 5.83 % | 6.40 % | 6.15 % | 7.30 % | 7.56 % | 11.84 % | 13.21 % | 13.10 % | 12.59 % | 12.22 % | 11.88 % | 11.82 % | 10.90 % |
| Others | 3.32 % | 41.58 % | 41.75 % | 38.73 % | 39.05 % | 24.59 % | 25.28 % | 40.12 % | 15.33 % | 37.12 % | 14.90 % | 15.03 % | 5.07 % | 5.52 % | 4.77 % | 4.64 % | 4.43 % | 4.42 % | 4.62 % | 4.58 % |
| No of Share Holders | 69 | 3,42,917 | 82,627 | 77,119 | 76,972 | 74,702 | 73,512 | 70,017 | 66,430 | 66,048 | 74,976 | 76,934 | 87,328 | 83,912 | 83,439 | 81,742 | 78,337 | 79,157 | 77,278 | 76,005 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 15 Dec 2023 |  Extraordinary General Meeting | NA | 15 Dec 2023 | 813.50 | 734.65 |
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 682.10 | 689.45 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 650.80 | 674.95 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 847.90 | 730.65 |
| 27 May 2025 | Quarterly Result Announcement | NA | 27 May 2025 | 732.15 | 977.00 |
| 02 Aug 2025 | Quarterly Result Announcement | NA | 02 Aug 2025 | 853.60 | 915.25 |
| 15 Sept 2025 | Annual General Meeting | NA | 15 Sept 2025 | 915.25 | 838.75 |
| 31 Oct 2025 | Quarterly Result Announcement | NA | 31 Oct 2025 | 757.45 | 757.85 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 808.25 | 772.30 |
| 20 May 2026 | Quarterly Result Announcement | NA | 20 May 2026 | 827.20 | 934.65 |
| 21 Jul 2026 | Quarterly Result Announcement | NA | 21 Jul 2026 | 822.15 | 801.30 |
| 17 Aug 2026 | Annual General Meeting | NA | 17 Aug 2026 | 795.40 | 668.75 |
Announcements
Board Comments On Fine Levied By The ExchangeSep 10, 2026
Sep 10, 2026Board Meeting Outcome for Outcome Of Board Meeting Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Sep 10, 2026
Sep 10, 2026Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Aug 26, 2026
Aug 26, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 26, 2026
Aug 26, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Aug 21, 2026
Aug 21, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 21, 2026
Aug 21, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 18, 2026
Aug 18, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMAug 17, 2026
Aug 17, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 06, 2026
Aug 06, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 05, 2026
Aug 05, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 01, 2026
Aug 01, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 31, 2026
Jul 31, 2026Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Jul 29, 2026
Jul 29, 2026Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Jul 29, 2026
Jul 29, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 29, 2026
Jul 29, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 29, 2026
Jul 29, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 28, 2026
Jul 28, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 24, 2026
Jul 24, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2026
Jul 24, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 24, 2026
Jul 24, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 24, 2026
Jul 24, 2026Business Responsibility and Sustainability Reporting (BRSR)Jul 23, 2026
Jul 23, 2026Notice Of 20Th Annual General Meeting Of The Company For The Financial Year 2025-26Jul 23, 2026
Jul 23, 2026Reg. 34 (1) Annual Report.Jul 23, 2026
Jul 23, 2026Board Meeting Outcome for Outcome Of The Board MeetingJul 23, 2026
Jul 23, 2026 Request To Ignore Inadvertent Filing Of Investor PresentationJul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2026
Jul 22, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJul 21, 2026
Jul 21, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJul 21, 2026
Jul 21, 2026Appointment of Company Secretary and Compliance OfficerJul 21, 2026
Jul 21, 2026Outcome Of Board Meeting Under SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jul 21, 2026
Jul 21, 2026Board Meeting Outcome for Outcome Of Board Meeting Under SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jul 21, 2026
Jul 21, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 15, 2026
Jul 15, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 15, 2026
Jul 15, 2026Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI LODR ")Jul 07, 2026
Jul 07, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 05, 2026
Jul 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2026
Jul 02, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 02, 2026
Jul 02, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2026
Jul 01, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 30, 2026
Jun 30, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 26, 2026
Jun 26, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 25, 2026
Jun 25, 2026Closure of Trading WindowJun 24, 2026
Jun 24, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 24, 2026
Jun 24, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 20, 2026
Jun 20, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 20, 2026
Jun 20, 2026Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 19, 2026
Jun 19, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 41.43
ATR(14)
Less Volatile 15.56
STOCH(9,6)
Neutral 39.37
STOCH RSI(14)
Neutral 59.23
MACD(12,26)
Bullish 1.80
ADX(14)
Weak Trend 16.67
UO(9)
Bearish 33.60
ROC(12)
Downtrend And Accelerating -1.29
WillR(14)
Neutral -69.95
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
